20
Participants
Start Date
December 22, 2022
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
Continuous Positive Airway Pressure Device (CPAP)
Metabolic studies will be performed before and after initiation of CPAP therapy, which is currently the first-line standard of care for treatment of patients with OSA, both with and without hypoxia.
Delayed Continuous Positive Airway Pressure Device (CPAP)
Metabolic studies will be performed before and after the study period of 12 weeks. After 12 weeks, participants will immediate receive CPAP therapy, which is currently the first-line standard of care for treatment of patients with OSA, both with and without hypoxia.
RECRUITING
University of California, San Francisco, San Francisco
University of California, San Francisco
OTHER